Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06945900 · ClinicalTrials.gov registry record
Emergency Medical Services (EMS) Telehealth to Speed STEMI Reperfusion
A clinical trial of STEMI - ST Elevation Myocardial Infarction, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- 35
- Enrollment target
- 1
- Study location
NCT06945900: Recruiting study of STEMI - ST Elevation Myocardial Infarction, sponsored by Wake Forest University Health Sciences.
NCT06945900 is a study of STEMI - ST Elevation Myocardial Infarction that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 35 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06945900, a study of STEMI - ST Elevation Myocardial Infarction, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to evaluate the impact of a Telehealth program on the time from First Medical Contact (FMC) to Reperfusion in STEMI (ST-elevation myocardial infarction) patients, by supporting local paramedics in their care delivery.
Primary Outcome
FMC to reperfusion time will be recorded in a study database. Data will be aggregated from patients before (baseline) and after EMS telehealth STEMI program implementation. FMC to reperfusion time will be reported as a mean with standard deviation and as a median with interquartile range.
Conditions Studied
Interventions
- OTHER Telehealth
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2025-06-18 |
| Est. Completion | 2028-12 |
What NCT06945900 shows while recruiting
NCT06945900 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target.
The record links to 1 condition, with STEMI - ST Elevation Myocardial Infarction appearing as the primary indexed condition, and to 1 intervention - of which Telehealth is the first listed.
NCT06945900 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06945900 about?
NCT06945900 is a clinical study titled "Emergency Medical Services (EMS) Telehealth to Speed STEMI Reperfusion". The aim of this study is to evaluate the impact of a Telehealth program on the time from First Medical Contact (FMC) to Reperfusion in STEMI (ST-elevation myocardial infarction) patients, by supporting local paramedics in their care delivery.
What is the current status of trial NCT06945900?
This trial is currently recruiting. The enrollment target is 35 participants. The study started on 2025-06-18. Estimated completion is 2028-12.
What conditions does trial NCT06945900 study?
This clinical trial studies the following conditions: STEMI - ST Elevation Myocardial Infarction.
What interventions are being tested in trial NCT06945900?
The interventions under investigation include: Telehealth (OTHER).
Who is sponsoring clinical trial NCT06945900?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06945900 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for STEMI - ST Elevation Myocardial Infarction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI